🇺🇸 FDA
Pipeline program

UB-421 SC(dB4C7C22-6 mAb)

UBP-A122-HIV

Phase 1 mab completed

Quick answer

UB-421 SC(dB4C7C22-6 mAb) for HIV-1 Infection is a Phase 1 program (mab) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
HIV-1 Infection
Phase
Phase 1
Modality
mab
Status
completed

Clinical trials